- Home
- WNEB vs TVGN Comparison
WNEB vs TVGN Comparison
Compare WNEB & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNEB
- TVGN
- Stock Information
- Founded
- WNEB 1853
- TVGN 2020
- Country
- WNEB United States
- TVGN United States
- Employees
- WNEB N/A
- TVGN N/A
- Industry
- WNEB Savings Institutions
- TVGN Blank Checks
- Sector
- WNEB Finance
- TVGN Finance
- Exchange
- WNEB Nasdaq
- TVGN Nasdaq
- Market Cap
- WNEB 191.1M
- TVGN 174.4M
- IPO Year
- WNEB N/A
- TVGN N/A
- Fundamental
- Price
- WNEB $9.35
- TVGN $1.43
- Analyst Decision
- WNEB Buy
- TVGN
- Analyst Count
- WNEB 3
- TVGN 0
- Target Price
- WNEB $9.75
- TVGN N/A
- AVG Volume (30 Days)
- WNEB 48.1K
- TVGN 4.9M
- Earning Date
- WNEB 01-28-2025
- TVGN 02-20-2025
- Dividend Yield
- WNEB 3.00%
- TVGN N/A
- EPS Growth
- WNEB N/A
- TVGN N/A
- EPS
- WNEB 0.56
- TVGN N/A
- Revenue
- WNEB $73,385,000.00
- TVGN N/A
- Revenue This Year
- WNEB N/A
- TVGN N/A
- Revenue Next Year
- WNEB $10.26
- TVGN N/A
- P/E Ratio
- WNEB $16.73
- TVGN N/A
- Revenue Growth
- WNEB N/A
- TVGN N/A
- 52 Week Low
- WNEB $6.00
- TVGN $0.26
- 52 Week High
- WNEB $10.08
- TVGN $21.09
- Technical
- Relative Strength Index (RSI)
- WNEB 58.60
- TVGN 54.34
- Support Level
- WNEB $9.25
- TVGN $1.30
- Resistance Level
- WNEB $9.47
- TVGN $1.54
- Average True Range (ATR)
- WNEB 0.16
- TVGN 0.17
- MACD
- WNEB 0.06
- TVGN 0.01
- Stochastic Oscillator
- WNEB 76.71
- TVGN 35.14
About WNEB Western New England Bancorp Inc.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the Company's revenues, profits, and assets are derived by the Bank from banking products and services.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.